Search clinical trials for: CEREVANCE

Total 7 results

Cerevance Beta, Inc.

Recruiting

Early Parkinson's Disease Monotherapy With CVN424

Parkinson's Disease

United States
Cerevance Beta, Inc.

Completed

Relative Bioavailability and Food Effect Study of CVN424

Parkinson Disease

United States
Cerevance

Completed

Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers

Tolerance | Safety Issues

Australia
Cerevance Alpha, Inc.

Completed

CVN058 Effect on Mismatch Negativity in Schizophrenics

Schizophrenia

United States
Cerevance Beta, Inc.

Completed

Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

Parkinson Disease

United States
University Hospital, Bordeaux

Completed

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. (VIGICAIRE)

Immunotherapy | Immune Thrombocytopenic Purpura | Autoimmune Hemolytic Anemia | Evan Syndrome
Cerevance Beta, Inc.

Completed

Study of CVN424 in Healthy Subjects (CVN424)

Healthy

United States

3

Subscribe